VW
BMY icon

Vantage Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Vantage Wealth’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-289,628
Closed -$15.7M – 34
2024
Q1 		$15.7M Sell
289,628
-27,516
-9% -$1.4M 3.66% 19
2023
Q4 		$16.3M Buy
317,144
+87,961
+38% +$4.62M 3.58% 21
2023
Q3 		$13.3M Buy
229,183
+7,845
+4% +$481K 3.33% 20
2023
Q2 		$14.2M Sell
221,338
-585
-0.3% -$39.2K 3.64% 22
2023
Q1 		$15.4M Sell
221,923
-2,955
-1% -$208K 4.27% 15
2022
Q4 		$16.2M Sell
224,878
-11,315
-5% -$853K 4.17% 12
2022
Q3 		$16.8M Sell
236,193
-1,487
-0.6% -$108K 4.63% 3
2022
Q2 		$18.3M Sell
237,680
-1,966
-0.8% -$150K 5.16% 2
2022
Q1 		$17.5M Buy
239,646
+8,030
+3% +$539K 3.89% 14
2021
Q4 		$14.4M Buy
231,616
+9,725
+4% +$570K 3.19% 23
2021
Q3 		$13.1M Buy
221,891
+8,153
+4% +$537K 3.36% 21
2021
Q2 		$14.3M Buy
213,738
+2,970
+1% +$194K 3.49% 17
2021
Q1 		$13.3M Buy
210,768
+1,875
+0.9% +$117K 3.4% 16
2020
Q4 		$13M Buy
208,893
+3,355
+2% +$206K 3.48% 16
2020
Q3 		$12.4M Buy
205,538
+5,540
+3% +$333K 3.98% 12
2020
Q2 		$11.8M Buy
199,998
+95
+0% +$5.68K 4.24% 6
2020
Q1 		$11.1M Buy
199,903
+18,433
+10% +$1.13M 4.74% 3
2019
Q4 		$11.6M Buy
181,470
+2,005
+1% +$115K 4.33% 4
2019
Q3 		$9.1M Buy
179,465
+2,620
+1% +$123K 3.72% 16
2019
Q2 		$8.02M Buy
+176,845
New +$8.24M 3.31% 22

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vantage Wealth's BMY Position: Q2 2024 in Review

Vantage Wealth sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 289,628 shares — an estimated $15.7M sold.

Vantage Wealth first reported a position in BMY in Q2 2019 and held it in 20 quarters. The position peaked at $18.3M in Q2 2022. 2,148 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • Vantage Wealth reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
  • Vantage Wealth sold 289,628 Bristol-Myers Squibb shares in Q2 2024, an estimated $15.7M.
  • Vantage Wealth first reported a position in Bristol-Myers Squibb in Q2 2019 and held it in 20 quarters.
  • Vantage Wealth's Bristol-Myers Squibb position peaked at $18.3M in Q2 2022.
  • 2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Vantage Wealth's 13F filing for Q2 2024, filed 16 Jul 2024.